All News

Preoperative urodynamic testing in women undergoing surgery for uncomplicated, stress-predominant urinary incontinence commonly results in a change in clinical diagnosis.

Mishaps around the home that lead to emergency room visits for genital injuries are common and may be preventable, according to a comprehensive survey of genital injuries over the last decade conducted by urologists at the University of California, San Francisco.

A recently published study supports the adoption of a new biomarker to measure the aggressiveness of primary prostate tumors.

Stereotactic body radiotherapy appears to be an effective treatment option for patients with organ-confined prostate cancer, according to two separate studies presented at the American Association for Radiation Oncology annual meeting in Boston.

An online poll of New England Journal of Medicine readers shows a lack of consensus over prostate cancer screening, with a little over half of respondents recommending screening for a 55-year-old man.

Urologists who treat Medicare patients face a 1% pay cut under a Centers for Medicare & Medicaid Services final rule with comment period issued Nov. 1.

Less than 5% of websites describing prostate cancer are written below a high school reading level, even though 90 million American adults read below this level, a new study found.

A new online medical database designed to help men diagnosed with low-grade prostate cancer track the progression of their disease while avoiding complications from overtreatment recently launched.

Stereotactic radiosurgery shows promise as a therapeutic option for patients with localized primary renal cancer who are considered poor surgical candidates and who do not have a prior history of pelvic or abdominal radiation, according to research presented at the American Society for Radiation Oncology annual meeting in Boston.

Annual PSA screening yields a greater quality-adjusted life expectancy among patients who have a high risk of developing metastatic disease in comparison to unscreened patients, according to a recent study.

A recent report from the Government Accountability Office (GAO) is highly critical of physician self-referral for advanced imaging services, indicating that it significantly raises Medicare costs.

The November election is over, but the real campaign has just begun. For urologists, that means urgent action on efforts to reverse the payment cuts mandated by the sustainable growth rate formula and the fiscal cliff, to name two immediate priorities.

Empiric use of antibiotics for a newly elevated PSA measurement in asymptomatic men appears to have no clinical benefit, according to results of a recent multicenter study.

Researchers at Northwestern University in Chicago are exploring the complex web woven by cytokines in uropathogenic Escherichia coli bladder infections and in so doing, are opening avenues for potential therapies for these infections.

Obesity may have a significant effect on prostate growth, a new analysis of the original data collected in a prospective, randomized, placebo-controlled clinical trial indicates.

A recent report from the Center for Public Integrity found that during a 10-year period, physicians increasingly billed Medicare for higher paying codes than in the past.

Patients younger than 50 years of age at the time of radical prostatectomy appear to have more favorable disease characteristics, data from a European consecutive cohort of non-screened men with clinically localized disease show.

A more thoughtful approach to antimicrobial prophylaxis is to obtain rectal swab cultures ahead of time and determine which bacteria are susceptible to antibiotics.

In this article, James M. Dupree, MD, MPH; Maddie Jones; and Christopher M. Gonzalez, MD, MBA explain what constitutes an accountable care organization and how a urologist might (or might not) interact with one.

Bicalutamide monotherapy in men with locally advanced or metastatic prostate cancer is as initially effective as LHRH analogs but can be far more beneficial in preserving bone mineral density, muscle tone, sexual function, and quality of life, say British researchers.

In this article, Joel M. Blau, CFP, and Ronald J. Paprocki, JD, CFP, CHBC discuss dynasty trusts and employee 401(k) programs.

In this article, Robert A. Dowling, MD, describes some of the important differences and practical aspects of Stage 2 meaningful use as they related to "eligible professionals."

Products and services in the pipeline from Nymox Pharmaceuticals Corp.; OncoGenex Pharmaceuticals, Inc.; Ampio Pharmaceuticals, Inc.; Aragon Pharmaceuticals; Sophiris Bio Inc.; Genomic Health, Inc.; OxThera AB; Aeterna Zentaris Inc.; and Tengion, Inc.

Photoselective laser vaporization of the prostate performed prior to external beam radiation therapy appears to be a viable approach for managing symptomatic BPH in men with concomitant prostate cancer, according to the findings of a retrospective study.

A screening protocol to guide antibiotic prophylaxis prior to prostate biopsy that eliminates the broth enrichment provides the best sensitivity with the fewest false- positive rates.

If a nephrostomy tube removal is performed in conjunction with another service, such as an evaluation and management service, you should either report the other service(s) documented and consider the nephrostomy tube removal incidental or add a –22 to the other service if documentation supports a significant increase in effort.

The latest products and services from Ethicon Endo-Surgery, InSightec Ltd., Watson Pharmaceuticals, Coloplast, Envaste Ltd., Cardinal Health, Medline Industries, Inc., and DocBookMD.

Here are some problems delayed billing present and how you can avoid them.

This list of U.S.-based National Institutes of Health trials is derived from the NIH's database and includes phase II, III, and IV urinary incontinence trials that are currently recruiting participants.

Men with moderate to severe lower urinary tract symptoms associated with BPH obtained significant symptom relief with the phosphodiesterase type-5 inhibitor tadalafil (Cialis) and the alpha-blocker tamsulosin (Flomax), both of which also improved urinary flow, results of a randomized trial showed.